Xanadu Quantum Technologies Ltd. (NASDAQ: XNDU) shares have declined over 36% since late May, validating a fair-value assessment from InvestingPro that flagged the stock as overpriced. The company, which develops photonic quantum processors, traded at $17.20 in late May before InvestingPro's models identified mispricing on May 27, 2026.
The fair-value estimate of $11.09 closely tracked the stock's subsequent decline, with shares falling to $10.95 by July 17, 2026. By publication date, Xanadu Quantum was trading at $9.99, surpassing the projected target. The stock had surged 280% in April before erasing gains with a 44% drop in May.
Fundamental pressures weighed on the valuation. Xanadu Quantum reported revenue of $7.2 million in its latest period, while EBITDA losses widened to $87.7 million, up from $73.6 million previously. Negative earnings per share stood at -$8.64. The company's market capitalization remains above $3.3 billion despite its shrinking revenue base.
Technical progress was noted, including a recent milestone in photonic chip packaging, but rising spending and expanding losses have offset positive developments. InvestingPro's fair-value analysis, which projected a 35% decline from the late-May price, has since aligned with market performance.
